Segigratinib
Segigratinib is a fibroblast growth factor receptor tyrosine kinase inhibitor, with antineoplastic effect[1].
Product Specifications
CAS Number
1882873-93-9
Product Name Alternative
3D185 (free base) ; HH185 (free base)
UNSPSC
12352005
Target
C-Fms; FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/segigratinib.html
Smiles
O=C(C1=CC=C(N2CCNC(C)(C2)C)C=C1)NC3=NNC4=C3C=CC(C5=C(Cl)C(OC)=CC(OC)=C5Cl)=N4
Molecular Formula
C27H28Cl2N6O3
Molecular Weight
555.46
References & Citations
[1]Segigratinib. WHO Drug Information, Vol. 37, No. 4, 2023.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GP-2001-5 1 mL
Colloidal Gold Conjugated Ricinus communis Lectin (Castor Bean) -RCA-I-, 5nm
Sign In for Pricing
View Details 
BNC740903-100 1x 100 µL
Cytokeratin 7 (KRT7/903), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details